Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 3 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 11, 2022 Filed Mar 16, 2022 00:57 UTC |
Gibson ChristopherDirector · Chief Executive Officer
|
ConversionClass A Common Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-019019 · doc4.xml · nonDerivative · entry 1 Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion of Class B Common Stock into Class A Common Stock. F2 · price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| March 07, 2022 Filed Mar 10, 2022 01:44 UTC |
Gibson ChristopherDirector · Chief Executive Officer
|
ConversionClass B Common Stock · Derivative | 300,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-017736 · doc4.xml · derivative · entry 3 Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,358,484 Underlying: Class A Common Stock · 7,358,484 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F1 · kind: Represents the conversion of Class B Common Stock into Class A Common Stock. F2 · price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| March 07, 2022 Filed Mar 10, 2022 01:44 UTC |
Gibson ChristopherDirector · Chief Executive Officer
|
SaleClass A Common Stock | 300,000 | $7.30 | $2,188,950.00 |
DisclosureSEC source: 0001209191-22-017736 · doc4.xml · nonDerivative · entry 2 Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,020 F3 · kind: Shares were sold by a lender to the Reporting Person to satisfy a margin call related to a loan in which the shares served as collateral. F4 · price: This transaction was executed in multiple trades at prices ranging from $7.06 to $7.74. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| March 07, 2022 Filed Mar 10, 2022 01:44 UTC |
Gibson ChristopherDirector · Chief Executive Officer
|
ConversionClass A Common Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-017736 · doc4.xml · nonDerivative · entry 1 Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 534,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion of Class B Common Stock into Class A Common Stock. F2 · price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| March 04, 2022 Filed Mar 9, 2022 01:55 UTC |
Marriott TinaPresident and COO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 58,500 | $0.00 Strike: $1.06 | $0.00 |
DisclosureSEC source: 0001209191-22-017387 · doc4.xml · derivative · entry 2 Larson Tina Marriott · CIK 0001856414 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 634,000 Underlying: Class A Common Stock · 634,000 shares Expires 2028-07-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (148th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date. Read SEC document |
| March 04, 2022 Filed Mar 9, 2022 01:55 UTC |
Marriott TinaPresident and COO
|
Exercise / conversionClass A Common Stock | 58,500 | $1.06 | $62,010.00 |
DisclosureSEC source: 0001209191-22-017387 · doc4.xml · nonDerivative · entry 1 Larson Tina Marriott · CIK 0001856414 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,018 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 01:00 UTC |
Doyle RamonaChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,625 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001209191-22-014405 · doc4.xml · derivative · entry 2 Doyle Ramona · CIK 0001856069 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 678,428 Underlying: Class A Common Stock · 678,428 shares Expires 2030-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Twenty-Five percent (25%) of the 750,000 shares originally subject to the award shall vest one year after December 31, 2020, or the Vesting Commencement Date, and one-forty-eighth (148th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 01:00 UTC |
Doyle RamonaChief Medical Officer
|
Exercise / conversionClass A Common Stock | 15,625 | $2.48 | $38,750.00 |
DisclosureSEC source: 0001209191-22-014405 · doc4.xml · nonDerivative · entry 1 Doyle Ramona · CIK 0001856069 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,870 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:24 UTC |
Gibson ChristopherDirector · Chief Executive Officer
|
ConversionClass B Common Stock · Derivative | 100,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012844 · doc4.xml · derivative · entry 3 Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,658,484 Underlying: Class A Common Stock · 7,658,484 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F1 · kind: Represents the conversion of Class B Common Stock into Class A Common Stock. F2 · price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:24 UTC |
Gibson ChristopherDirector · Chief Executive Officer
|
SaleClass A Common Stock | 100,000 | $10.22 | $1,021,540.00 |
DisclosureSEC source: 0001209191-22-012844 · doc4.xml · nonDerivative · entry 2 Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,020 F3 · kind: Shares were sold by a lender to the Reporting Person to satisfy a margin call related to a loan in which the shares served as collateral. F4 · price: This transaction was executed in multiple trades at prices ranging from $9.91 to $10.61. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:24 UTC |
Gibson ChristopherDirector · Chief Executive Officer
|
ConversionClass A Common Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012844 · doc4.xml · nonDerivative · entry 1 Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion of Class B Common Stock into Class A Common Stock. F2 · price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 00:58 UTC |
Marriott TinaPresident and COO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $1.06 | $0.00 |
DisclosureSEC source: 0001209191-22-011969 · doc4.xml · derivative · entry 2 Larson Tina Marriott · CIK 0001856414 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 692,500 Underlying: Class A Common Stock · 692,500 shares Expires 2028-07-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (148th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 00:58 UTC |
Marriott TinaPresident and COO
|
Exercise / conversionClass A Common Stock | 16,000 | $1.06 | $16,960.00 |
DisclosureSEC source: 0001209191-22-011969 · doc4.xml · nonDerivative · entry 1 Larson Tina Marriott · CIK 0001856414 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:04 UTC |
Marriott TinaPresident and COO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $1.06 | $0.00 |
DisclosureSEC source: 0001209191-22-010496 · doc4.xml · derivative · entry 2 Larson Tina Marriott · CIK 0001856414 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 708,500 Underlying: Class A Common Stock · 708,500 shares Expires 2028-07-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (148th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 11:04 UTC |
Marriott TinaPresident and COO
|
Exercise / conversionClass A Common Stock | 4,000 | $1.06 | $4,240.00 |
DisclosureSEC source: 0001209191-22-010496 · doc4.xml · nonDerivative · entry 1 Larson Tina Marriott · CIK 0001856414 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:03 UTC |
Gibson ChristopherDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 5,436 | $0.00 Strike: $11.40 | $0.00 |
DisclosureSEC source: 0001209191-22-007909 · doc4.xml · derivative · entry 5 Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,436 Underlying: Class A Common Stock · 5,436 shares Expires 2032-02-04 Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:03 UTC |
Gibson ChristopherDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 416,350 | $0.00 Strike: $11.40 | $0.00 |
DisclosureSEC source: 0001209191-22-007909 · doc4.xml · derivative · entry 4 Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 416,350 Underlying: Class A Common Stock · 416,350 shares Expires 2032-02-04 F3 · derivative.exercise_date: The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:03 UTC |
Gibson ChristopherDirector · Chief Executive Officer
|
Tax withholdingClass A Common Stock | 343 | $11.40 | $3,910.20 |
DisclosureSEC source: 0001209191-22-007909 · doc4.xml · nonDerivative · entry 3 Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,020 Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:03 UTC |
Gibson ChristopherDirector · Chief Executive Officer
|
GrantClass A Common Stock | 2,718 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007909 · doc4.xml · nonDerivative · entry 2 Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,363 F2 · kind: This RSU vested immediately upon the grant date. Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:03 UTC |
Gibson ChristopherDirector · Chief Executive Officer
|
GrantClass A Common Stock | 208,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007909 · doc4.xml · nonDerivative · entry 1 Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,645 F1 · kind: This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2022 and every three months thereafter. Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:11 UTC |
Virani ShafiqueChief Corp. Dev. Officer
|
GrantStock Option (Right to Buy) · Derivative | 5,436 | $0.00 Strike: $11.40 | $0.00 |
DisclosureSEC source: 0001209191-22-007918 · doc4.xml · derivative · entry 5 Virani Shafique · CIK 0001856081 · Chief Corp. Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,436 Underlying: Class A Common Stock · 5,436 shares Expires 2032-02-04 Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:11 UTC |
Virani ShafiqueChief Corp. Dev. Officer
|
GrantStock Option (Right to Buy) · Derivative | 80,450 | $0.00 Strike: $11.40 | $0.00 |
DisclosureSEC source: 0001209191-22-007918 · doc4.xml · derivative · entry 4 Virani Shafique · CIK 0001856081 · Chief Corp. Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,450 Underlying: Class A Common Stock · 80,450 shares Expires 2032-02-04 F4 · derivative.exercise_date: The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter. Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:11 UTC |
Virani ShafiqueChief Corp. Dev. Officer
|
Tax withholdingClass A Common Stock | 1,114 | $11.40 | $12,699.60 |
DisclosureSEC source: 0001209191-22-007918 · doc4.xml · nonDerivative · entry 3 Virani Shafique · CIK 0001856081 · Chief Corp. Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,256 Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:11 UTC |
Virani ShafiqueChief Corp. Dev. Officer
|
GrantClass A Common Stock | 2,718 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007918 · doc4.xml · nonDerivative · entry 2 Virani Shafique · CIK 0001856081 · Chief Corp. Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,370 F3 · kind: This RSU vested immediately upon the grant date. Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:11 UTC |
Virani ShafiqueChief Corp. Dev. Officer
|
GrantClass A Common Stock | 40,225 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007918 · doc4.xml · nonDerivative · entry 1 Virani Shafique · CIK 0001856081 · Chief Corp. Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,652 F1 · kind: This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2022 and every three months thereafter. F2 · balance_after: Includes 382 shares purchased pursuant to the Issuer's Employee Stock Purchase Plan on November 22, 2021. Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:09 UTC |
Doyle RamonaChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 4,784 | $0.00 Strike: $11.40 | $0.00 |
DisclosureSEC source: 0001209191-22-007915 · doc4.xml · derivative · entry 5 Doyle Ramona · CIK 0001856069 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,784 Underlying: Class A Common Stock · 4,784 shares Expires 2032-02-04 Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:09 UTC |
Doyle RamonaChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 76,998 | $0.00 Strike: $11.40 | $0.00 |
DisclosureSEC source: 0001209191-22-007915 · doc4.xml · derivative · entry 4 Doyle Ramona · CIK 0001856069 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,998 Underlying: Class A Common Stock · 76,998 shares Expires 2032-02-04 F3 · derivative.exercise_date: The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter. Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:09 UTC |
Doyle RamonaChief Medical Officer
|
Tax withholdingClass A Common Stock | 981 | $11.40 | $11,183.40 |
DisclosureSEC source: 0001209191-22-007915 · doc4.xml · nonDerivative · entry 3 Doyle Ramona · CIK 0001856069 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,245 Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:09 UTC |
Doyle RamonaChief Medical Officer
|
GrantClass A Common Stock | 2,392 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007915 · doc4.xml · nonDerivative · entry 2 Doyle Ramona · CIK 0001856069 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,226 F2 · kind: This RSU vested immediately upon the grant date. Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:09 UTC |
Doyle RamonaChief Medical Officer
|
GrantClass A Common Stock | 38,499 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007915 · doc4.xml · nonDerivative · entry 1 Doyle Ramona · CIK 0001856069 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,834 F1 · kind: This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2022 and every three months thereafter. Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:07 UTC |
Secora MichaelChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 3,914 | $0.00 Strike: $11.40 | $0.00 |
DisclosureSEC source: 0001209191-22-007913 · doc4.xml · derivative · entry 5 Secora Michael · CIK 0001855980 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,914 Underlying: Class A Common Stock · 3,914 shares Expires 2032-02-04 Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:07 UTC |
Secora MichaelChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 116,684 | $0.00 Strike: $11.40 | $0.00 |
DisclosureSEC source: 0001209191-22-007913 · doc4.xml · derivative · entry 4 Secora Michael · CIK 0001855980 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,684 Underlying: Class A Common Stock · 116,684 shares Expires 2032-02-04 F4 · derivative.exercise_date: The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter. Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:07 UTC |
Secora MichaelChief Financial Officer
|
Tax withholdingClass A Common Stock | 678 | $11.40 | $7,729.20 |
DisclosureSEC source: 0001209191-22-007913 · doc4.xml · nonDerivative · entry 3 Secora Michael · CIK 0001855980 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 589,771 Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:07 UTC |
Secora MichaelChief Financial Officer
|
GrantClass A Common Stock | 1,957 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007913 · doc4.xml · nonDerivative · entry 2 Secora Michael · CIK 0001855980 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 590,449 F3 · kind: This RSU vested immediately upon the grant date. Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:07 UTC |
Secora MichaelChief Financial Officer
|
GrantClass A Common Stock | 58,342 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007913 · doc4.xml · nonDerivative · entry 1 Secora Michael · CIK 0001855980 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 588,492 F1 · kind: This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2022 and every three months thereafter. F2 · balance_after: Includes 1,388 shares purchased pursuant to the Issuer's Employee Stock Purchase Plan on November 22, 2021. Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:05 UTC |
Marriott TinaPresident and COO
|
GrantStock Option (Right to Buy) · Derivative | 4,784 | $0.00 Strike: $11.40 | $0.00 |
DisclosureSEC source: 0001209191-22-007911 · doc4.xml · derivative · entry 5 Larson Tina Marriott · CIK 0001856414 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,784 Underlying: Class A Common Stock · 4,784 shares Expires 2032-02-04 Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:05 UTC |
Marriott TinaPresident and COO
|
GrantStock Option (Right to Buy) · Derivative | 159,226 | $0.00 Strike: $11.40 | $0.00 |
DisclosureSEC source: 0001209191-22-007911 · doc4.xml · derivative · entry 4 Larson Tina Marriott · CIK 0001856414 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,226 Underlying: Class A Common Stock · 159,226 shares Expires 2032-02-04 F4 · derivative.exercise_date: The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter. Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:05 UTC |
Marriott TinaPresident and COO
|
Tax withholdingClass A Common Stock | 828 | $11.40 | $9,439.20 |
DisclosureSEC source: 0001209191-22-007911 · doc4.xml · nonDerivative · entry 3 Larson Tina Marriott · CIK 0001856414 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,518 Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:05 UTC |
Marriott TinaPresident and COO
|
GrantClass A Common Stock | 2,392 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007911 · doc4.xml · nonDerivative · entry 2 Larson Tina Marriott · CIK 0001856414 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,346 F3 · kind: This RSU vested immediately upon the grant date. Read SEC document |
| February 04, 2022 Filed Feb 9, 2022 02:05 UTC |
Marriott TinaPresident and COO
|
GrantClass A Common Stock | 79,613 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007911 · doc4.xml · nonDerivative · entry 1 Larson Tina Marriott · CIK 0001856414 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,954 F1 · kind: This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2022 and every three months thereafter. F2 · balance_after: Includes 841 shares purchased pursuant to the Issuer's Employee Stock Purchase Plan on November 22, 2021. Read SEC document |
| February 04, 2022 Filed Apr 28, 2023 20:30 UTC Amendment |
Secora MichaelChief Financial Officer
|
Tax withholdingClass A Common Stock | 678 | $11.40 | $7,729.20 |
DisclosureSEC source: 0001209191-23-026036 · doc4a.xml · nonDerivative · entry 3 Secora Michael · CIK 0001855980 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 590,380 F2 · balance_after: Includes 1,388 shares purchased pursuant to the Issuer's Employee Stock Purchase Plan on November 22, 2021 and 609 shares received pursuant to a pro rata distribution from Catalio Nexus Fund II, LP, of which the Reporting Person was a limited partner (the acquisition of such shares from Catalio was inadvertently excluded from the total shares held in the original Form 4 filing and is exempt pursuant to Rule 16a-9). Read SEC document |
| February 04, 2022 Filed Apr 28, 2023 20:30 UTC Amendment |
Secora MichaelChief Financial Officer
|
GrantClass A Common Stock | 1,957 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-026036 · doc4a.xml · nonDerivative · entry 2 Secora Michael · CIK 0001855980 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 591,058 F3 · kind: This RSU vested immediately upon the grant date. F2 · balance_after: Includes 1,388 shares purchased pursuant to the Issuer's Employee Stock Purchase Plan on November 22, 2021 and 609 shares received pursuant to a pro rata distribution from Catalio Nexus Fund II, LP, of which the Reporting Person was a limited partner (the acquisition of such shares from Catalio was inadvertently excluded from the total shares held in the original Form 4 filing and is exempt pursuant to Rule 16a-9). Read SEC document |
| February 04, 2022 Filed Apr 28, 2023 20:30 UTC Amendment |
Secora MichaelChief Financial Officer
|
GrantClass A Common Stock | 58,342 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-026036 · doc4a.xml · nonDerivative · entry 1 Secora Michael · CIK 0001855980 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 589,101 F1 · kind: This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2022 and every three months thereafter. F2 · balance_after: Includes 1,388 shares purchased pursuant to the Issuer's Employee Stock Purchase Plan on November 22, 2021 and 609 shares received pursuant to a pro rata distribution from Catalio Nexus Fund II, LP, of which the Reporting Person was a limited partner (the acquisition of such shares from Catalio was inadvertently excluded from the total shares held in the original Form 4 filing and is exempt pursuant to Rule 16a-9). Read SEC document |
| January 31, 2022 Filed Feb 3, 2022 01:09 UTC |
Gibson ChristopherDirector · Chief Executive Officer
|
ConversionClass B Common Stock · Derivative | 19,858 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006596 · doc4.xml · derivative · entry 3 Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,758,484 Underlying: Class A Common Stock · 19,858 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F4 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F4 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| January 31, 2022 Filed Feb 3, 2022 01:09 UTC |
Gibson ChristopherDirector · Chief Executive Officer
|
SaleClass A Common Stock | 19,858 | $11.73 | $232,964.13 |
DisclosureSEC source: 0001209191-22-006596 · doc4.xml · nonDerivative · entry 2 Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,470 F2 · kind: Shares were sold by a lender to the Reporting Person to satisfy a margin call related to a loan in which the shares served as collateral. F3 · price: This transaction was executed in multiple trades at prices ranging from $11.43 to $11.85. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| January 31, 2022 Filed Feb 3, 2022 01:09 UTC |
Gibson ChristopherDirector · Chief Executive Officer
|
ConversionClass A Common Stock | 19,858 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006596 · doc4.xml · nonDerivative · entry 1 Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,328 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion of Class B Common Stock into Class A Common Stock. Read SEC document |
| January 31, 2022 Filed Feb 3, 2022 01:11 UTC |
Doyle RamonaChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,625 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001209191-22-006598 · doc4.xml · derivative · entry 2 Doyle Ramona · CIK 0001856069 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 694,053 Underlying: Class A Common Stock · 15,625 shares Expires 2030-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person. F3 · derivative.exercise_date: Twenty-Five percent (25%) of the 750,000 shares originally subject to the award shall vest one year after December 31, 2020, or the Vesting Commencement Date, and one-forty-eighth (148th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date. Read SEC document |
| January 31, 2022 Filed Feb 3, 2022 01:11 UTC |
Doyle RamonaChief Medical Officer
|
Exercise / conversionClass A Common Stock | 15,625 | $2.48 | $38,750.00 |
DisclosureSEC source: 0001209191-22-006598 · doc4.xml · nonDerivative · entry 1 Doyle Ramona · CIK 0001856069 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person. F2 · balance_after: Includes 1,388 shares purchased pursuant to the Issuer's Employee Stock Purchase Plan on November 22, 2021 Read SEC document |
| January 14, 2022 Filed Jan 15, 2022 01:42 UTC |
Gibson ChristopherDirector · Chief Executive Officer
|
ConversionClass B Common Stock · Derivative | 254,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-003402 · doc4.xml · derivative · entry 8 Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,778,342 Underlying: Class A Common Stock · 254,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F6 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F6 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| January 14, 2022 Filed Jan 15, 2022 01:42 UTC |
Gibson ChristopherDirector · Chief Executive Officer
|
SaleClass A Common Stock | 254,000 | $13.57 | $3,445,611.60 |
DisclosureSEC source: 0001209191-22-003402 · doc4.xml · nonDerivative · entry 5 Gibson Christopher · CIK 0001856369 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,470 F2 · kind: Shares were sold by a lender to the Reporting Person to satisfy a margin call related to a loan in which the shares served as collateral. F5 · price: This transaction was executed in multiple trades at prices ranging from $13.09 to $14.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.